Claritev generated fourth quarter 2025 revenues of 246554000, up year-over-year, with a net loss of 80570000 and Adjusted EBITDA of 151326000. The company delivered positive free cash flow and significant medical cost savings from processed claims.

Claritev Corporation, formerly known as MultiPlan, reported a decrease in revenues to $232.1 million and a net loss of $138.0 million for Q4 2024. The company is celebrating its rebranding launch and focusing on making healthcare more affordable.

MultiPlan Corporation reported Q3 2024 revenues of $230.5 million, a net loss of $391.5 million (including a $361.6 million impairment), and Adjusted EBITDA of $141.6 million. The company identified approximately $6.4 billion in potential medical cost savings during the quarter.

MultiPlan Corporation reported Q2 2024 financial results with revenues of $233.5 million, a net loss of $576.7 million (including a $553.7 million impairment of goodwill), and an adjusted EBITDA of $146.7 million. The company updated its full-year 2024 guidance, lowering revenue and adjusted EBITDA expectations.

MultiPlan reported Q1 2024 revenues of $234.5 million, a net loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and adjusted EBITDA of $146.8 million. The company identified potential medical cost savings of approximately $5.7 billion and repurchased or repaid $24.4 million of debt.

MultiPlan Corporation reported a 1.3% increase in revenues to $244.1 million for Q4 2023, with a net loss of $31.4 million and an adjusted EBITDA of $156.8 million. The company identified $5.9 billion in potential medical cost savings during the quarter.

MultiPlan Corporation reported a decrease in revenue to $242.8 million, a net loss of $24.1 million, and an adjusted EBITDA of $152.3 million for Q3 2023. The company saw a decrease compared to the previous year, but is on track to deliver on its full-year 2023 guidance.

MultiPlan Corporation reported Q2 2023 revenues of $238.0 million, a net loss of $36.4 million, and Adjusted EBITDA of $152.7 million. The company acquired Benefits Science Technologies and partnered with ECHO Health during the quarter. They are increasing the midpoint of revenue guidance for full-year 2023.

MultiPlan Corporation reported a decrease in revenues, net income, and Adjusted EBITDA for Q1 2023 compared to Q1 2022, but saw a 3% increase in potential medical cost savings compared to Q4 2022. The company is focused on executing its Growth Plan and launching new products, expecting to accelerate growth in 2024 and beyond.

MultiPlan Corporation reported a decrease in revenues to $241.1 million for Q4 2022, a 19.2% decrease over Q4 2021. The company reported a net loss of $650.1 million, including a $662.2 million impairment charge for goodwill and indefinite-lived intangible assets.

MultiPlan reported Q3 2022 revenues of $250.5 million, a decrease of 13.1% compared to Q3 2021. Net income decreased by 74.8% to $19.7 million, and Adjusted EBITDA decreased by 21.2% to $172.2 million. The decline was primarily attributed to lower volumes and an unfavorable mix of identified potential medical cost savings.

MultiPlan reported a 5.0% increase in revenues, reaching $290.1 million, and a net income of $13.5 million for Q2 2022, compared to a net loss in Q2 2021. The company also saw growth in adjusted EBITDA and free cash flow.

MultiPlan Corporation reported Q1 2022 revenues of $298.0 million, a 16.9% increase over Q1 2021. Net income was $44.0 million, and Adjusted EBITDA was $225.4 million. The company processed approximately $31.7 billion in claim charges, identifying potential medical cost savings of approximately $5.6 billion.

MultiPlan reported record fourth quarter and full year 2021 results, with Q4 revenues of $298.3 million, net income of $24.9 million, and adjusted EBITDA of $223.6 million. The growth was driven by increased volumes and strong savings performance across all lines of business.

MultiPlan Corporation reported financial results for the third quarter ended September 30, 2021. Q3 2021 Revenues were $288.2 million and Net Income was $78.2 million.

MultiPlan reported Q1 2021 revenues of $254.9 million and net income of $45.9 million. The company processed approximately $29 billion in claims during the quarter, identifying potential medical cost savings of approximately $4.9 billion. Full year 2021 revenue guidance is $1.04 billion to $1.10 billion.

MultiPlan reported strong consecutive quarterly growth and performed better than anticipated amidst the pandemic. The company processed a record $27.8 billion in claims during the third quarter, identifying potential savings of approximately $4.8 billion.